The improving environment for deals is encouraging some smaller firms to start hunting much larger prey.Most Read from ...
In a landmark move for English cricket, stakes in each of the eight teams in The Hundred are being sold. It has been a ...
The company has a lower Return on Equity (ROE) of 8.17%, which is 4.87% below the industry average. This indicates potential ...
Goldman Sachs analyst Matthew Sykes double downgraded Cytek Biosciences (CTKB) to Sell from Buy with a price target of $4.50, down from $7. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback